Copyright Reports & Markets. All rights reserved.

Global Oxaliplatin Injection Market Research Report 2021

Request for Sample of this report
Buy now

1 Oxaliplatin Injection Market Overview

  • 1.1 Product Overview and Scope of Oxaliplatin Injection
  • 1.2 Oxaliplatin Injection Segment by Type
    • 1.2.1 Global Oxaliplatin Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Mannitol
    • 1.2.3 Glucose Solution
    • 1.2.4 Lactose Solution
    • 1.2.5 Other
  • 1.3 Oxaliplatin Injection Segment by Application
    • 1.3.1 Oxaliplatin Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Colorectal Cancer
    • 1.3.3 Stomach Cancer
    • 1.3.4 Ovarian Cancer
    • 1.3.5 Other
  • 1.4 Global Oxaliplatin Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Oxaliplatin Injection Revenue 2016-2027
    • 1.4.2 Global Oxaliplatin Injection Sales 2016-2027
    • 1.4.3 Oxaliplatin Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Oxaliplatin Injection Market Competition by Manufacturers

  • 2.1 Global Oxaliplatin Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Oxaliplatin Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Oxaliplatin Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Oxaliplatin Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Oxaliplatin Injection Market Competitive Situation and Trends
    • 2.5.1 Oxaliplatin Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Oxaliplatin Injection Players Market Share by Revenue
    • 2.5.3 Global Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oxaliplatin Injection Retrospective Market Scenario by Region

  • 3.1 Global Oxaliplatin Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Oxaliplatin Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Oxaliplatin Injection Market Facts & Figures by Country
    • 3.3.1 North America Oxaliplatin Injection Sales by Country
    • 3.3.2 North America Oxaliplatin Injection Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Oxaliplatin Injection Market Facts & Figures by Country
    • 3.4.1 Europe Oxaliplatin Injection Sales by Country
    • 3.4.2 Europe Oxaliplatin Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Oxaliplatin Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Oxaliplatin Injection Sales by Region
    • 3.5.2 Asia Pacific Oxaliplatin Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Oxaliplatin Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Oxaliplatin Injection Sales by Country
    • 3.6.2 Latin America Oxaliplatin Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Oxaliplatin Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Oxaliplatin Injection Sales by Country
    • 3.7.2 Middle East and Africa Oxaliplatin Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Oxaliplatin Injection Historic Market Analysis by Type

  • 4.1 Global Oxaliplatin Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Oxaliplatin Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Oxaliplatin Injection Price by Type (2016-2021)

5 Global Oxaliplatin Injection Historic Market Analysis by Application

  • 5.1 Global Oxaliplatin Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Oxaliplatin Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Oxaliplatin Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Sanofi-Aventis
    • 6.1.1 Sanofi-Aventis Corporation Information
    • 6.1.2 Sanofi-Aventis Description and Business Overview
    • 6.1.3 Sanofi-Aventis Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Sanofi-Aventis Product Portfolio
    • 6.1.5 Sanofi-Aventis Recent Developments/Updates
  • 6.2 Yakult honsha
    • 6.2.1 Yakult honsha Corporation Information
    • 6.2.2 Yakult honsha Description and Business Overview
    • 6.2.3 Yakult honsha Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Yakult honsha Product Portfolio
    • 6.2.5 Yakult honsha Recent Developments/Updates
  • 6.3 Dr Reddy's laboratories
    • 6.3.1 Dr Reddy's laboratories Corporation Information
    • 6.3.2 Dr Reddy's laboratories Description and Business Overview
    • 6.3.3 Dr Reddy's laboratories Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Dr Reddy's laboratories Product Portfolio
    • 6.3.5 Dr Reddy's laboratories Recent Developments/Updates
  • 6.4 Sun Pharmaceutical
    • 6.4.1 Sun Pharmaceutical Corporation Information
    • 6.4.2 Sun Pharmaceutical Description and Business Overview
    • 6.4.3 Sun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sun Pharmaceutical Product Portfolio
    • 6.4.5 Sun Pharmaceutical Recent Developments/Updates
  • 6.5 Teva
    • 6.5.1 Teva Corporation Information
    • 6.5.2 Teva Description and Business Overview
    • 6.5.3 Teva Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Teva Product Portfolio
    • 6.5.5 Teva Recent Developments/Updates
  • 6.6 Fresenius Kabi
    • 6.6.1 Fresenius Kabi Corporation Information
    • 6.6.2 Fresenius Kabi Description and Business Overview
    • 6.6.3 Fresenius Kabi Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Fresenius Kabi Product Portfolio
    • 6.6.5 Fresenius Kabi Recent Developments/Updates
  • 6.7 Hospira(Pfizer)
    • 6.6.1 Hospira(Pfizer) Corporation Information
    • 6.6.2 Hospira(Pfizer) Description and Business Overview
    • 6.6.3 Hospira(Pfizer) Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hospira(Pfizer) Product Portfolio
    • 6.7.5 Hospira(Pfizer) Recent Developments/Updates
  • 6.8 Mylan
    • 6.8.1 Mylan Corporation Information
    • 6.8.2 Mylan Description and Business Overview
    • 6.8.3 Mylan Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Mylan Product Portfolio
    • 6.8.5 Mylan Recent Developments/Updates
  • 6.9 Jiangsu Hengrui Medicine
    • 6.9.1 Jiangsu Hengrui Medicine Corporation Information
    • 6.9.2 Jiangsu Hengrui Medicine Description and Business Overview
    • 6.9.3 Jiangsu Hengrui Medicine Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Jiangsu Hengrui Medicine Product Portfolio
    • 6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
  • 6.10 Nanjing Pharmaceutical Factory
    • 6.10.1 Nanjing Pharmaceutical Factory Corporation Information
    • 6.10.2 Nanjing Pharmaceutical Factory Description and Business Overview
    • 6.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Nanjing Pharmaceutical Factory Product Portfolio
    • 6.10.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
  • 6.11 Jiangsu Aosaikang Pharmaceutical
    • 6.11.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
    • 6.11.2 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Description and Business Overview
    • 6.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Jiangsu Aosaikang Pharmaceutical Product Portfolio
    • 6.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
  • 6.12 Qilu Pharmaceutical
    • 6.12.1 Qilu Pharmaceutical Corporation Information
    • 6.12.2 Qilu Pharmaceutical Oxaliplatin Injection Description and Business Overview
    • 6.12.3 Qilu Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Qilu Pharmaceutical Product Portfolio
    • 6.12.5 Qilu Pharmaceutical Recent Developments/Updates
  • 6.13 Hisun Pharmaceutical
    • 6.13.1 Hisun Pharmaceutical Corporation Information
    • 6.13.2 Hisun Pharmaceutical Oxaliplatin Injection Description and Business Overview
    • 6.13.3 Hisun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Hisun Pharmaceutical Product Portfolio
    • 6.13.5 Hisun Pharmaceutical Recent Developments/Updates
  • 6.14 Lunan Pharmaceutical
    • 6.14.1 Lunan Pharmaceutical Corporation Information
    • 6.14.2 Lunan Pharmaceutical Oxaliplatin Injection Description and Business Overview
    • 6.14.3 Lunan Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Lunan Pharmaceutical Product Portfolio
    • 6.14.5 Lunan Pharmaceutical Recent Developments/Updates
  • 6.15 Luoxin
    • 6.15.1 Luoxin Corporation Information
    • 6.15.2 Luoxin Oxaliplatin Injection Description and Business Overview
    • 6.15.3 Luoxin Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Luoxin Product Portfolio
    • 6.15.5 Luoxin Recent Developments/Updates
  • 6.16 Halfsky Pharmacy
    • 6.16.1 Halfsky Pharmacy Corporation Information
    • 6.16.2 Halfsky Pharmacy Oxaliplatin Injection Description and Business Overview
    • 6.16.3 Halfsky Pharmacy Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Halfsky Pharmacy Product Portfolio
    • 6.16.5 Halfsky Pharmacy Recent Developments/Updates
  • 6.17 YRPG
    • 6.17.1 YRPG Corporation Information
    • 6.17.2 YRPG Oxaliplatin Injection Description and Business Overview
    • 6.17.3 YRPG Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 YRPG Product Portfolio
    • 6.17.5 YRPG Recent Developments/Updates
  • 6.18 Hainan Jinrui Pharmaceutical
    • 6.18.1 Hainan Jinrui Pharmaceutical Corporation Information
    • 6.18.2 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Description and Business Overview
    • 6.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Hainan Jinrui Pharmaceutical Product Portfolio
    • 6.18.5 Hainan Jinrui Pharmaceutical Recent Developments/Updates
  • 6.19 Jari Pharmaceutical
    • 6.19.1 Jari Pharmaceutical Corporation Information
    • 6.19.2 Jari Pharmaceutical Oxaliplatin Injection Description and Business Overview
    • 6.19.3 Jari Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Jari Pharmaceutical Product Portfolio
    • 6.19.5 Jari Pharmaceutical Recent Developments/Updates
  • 6.20 Chiatai Tianqing
    • 6.20.1 Chiatai Tianqing Corporation Information
    • 6.20.2 Chiatai Tianqing Oxaliplatin Injection Description and Business Overview
    • 6.20.3 Chiatai Tianqing Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Chiatai Tianqing Product Portfolio
    • 6.20.5 Chiatai Tianqing Recent Developments/Updates

7 Oxaliplatin Injection Manufacturing Cost Analysis

  • 7.1 Oxaliplatin Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Oxaliplatin Injection
  • 7.4 Oxaliplatin Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Oxaliplatin Injection Distributors List
  • 8.3 Oxaliplatin Injection Customers

9 Oxaliplatin Injection Market Dynamics

  • 9.1 Oxaliplatin Injection Industry Trends
  • 9.2 Oxaliplatin Injection Growth Drivers
  • 9.3 Oxaliplatin Injection Market Challenges
  • 9.4 Oxaliplatin Injection Market Restraints

10 Global Market Forecast

  • 10.1 Oxaliplatin Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Oxaliplatin Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Oxaliplatin Injection by Type (2022-2027)
  • 10.2 Oxaliplatin Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Oxaliplatin Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Oxaliplatin Injection by Application (2022-2027)
  • 10.3 Oxaliplatin Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Oxaliplatin Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Oxaliplatin Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Mannitol
    Glucose Solution
    Lactose Solution
    Other

    Segment by Application
    Colorectal Cancer
    Stomach Cancer
    Ovarian Cancer
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Sanofi-Aventis
    Yakult honsha
    Dr Reddy's laboratories
    Sun Pharmaceutical
    Teva
    Fresenius Kabi
    Hospira(Pfizer)
    Mylan
    Jiangsu Hengrui Medicine
    Nanjing Pharmaceutical Factory
    Jiangsu Aosaikang Pharmaceutical
    Qilu Pharmaceutical
    Hisun Pharmaceutical
    Lunan Pharmaceutical
    Luoxin
    Halfsky Pharmacy
    YRPG
    Hainan Jinrui Pharmaceutical
    Jari Pharmaceutical
    Chiatai Tianqing

    Buy now